[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e4158f6f5f8d20c82ed7a730688f4f72822e4c96154c22cdc7fb81ec5e2705a7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741970460,
      "headline": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "id": 133222588,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e4158f6f5f8d20c82ed7a730688f4f72822e4c96154c22cdc7fb81ec5e2705a7"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer On Regeneron Pharmaceuticals Inc. (REGN) – “I Want You to Own It”",
    "summary": "We recently published a list of What Did Jim Cramer Say About These 19 Stocks Recently? In this article, we are going to take a look at where Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) stands against other stocks that Jim Cramer discussed recently. Jim Cramer kicked off his latest episode of Mad Money by highlighting the wild […]",
    "url": "https://finnhub.io/api/news?id=4885e243eb1354b42c0b58a3023e670330003ec79062a0445a84914bbb976a4d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741966676,
      "headline": "Jim Cramer On Regeneron Pharmaceuticals Inc. (REGN) – “I Want You to Own It”",
      "id": 133186686,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "We recently published a list of What Did Jim Cramer Say About These 19 Stocks Recently? In this article, we are going to take a look at where Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) stands against other stocks that Jim Cramer discussed recently. Jim Cramer kicked off his latest episode of Mad Money by highlighting the wild […]",
      "url": "https://finnhub.io/api/news?id=4885e243eb1354b42c0b58a3023e670330003ec79062a0445a84914bbb976a4d"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Has Lost Its Way, But Can It Find It Again?",
    "summary": "Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for more on REGN stock news.",
    "url": "https://finnhub.io/api/news?id=5b375f110a67ecf83936bf4bee953fea25a4043611ffce7bcba7609d1cc03b8c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741945228,
      "headline": "Regeneron Pharmaceuticals Has Lost Its Way, But Can It Find It Again?",
      "id": 133168922,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/168166178/image_168166178.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for more on REGN stock news.",
      "url": "https://finnhub.io/api/news?id=5b375f110a67ecf83936bf4bee953fea25a4043611ffce7bcba7609d1cc03b8c"
    }
  }
]